Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypnozoites are dormant liver-stage forms of certain Plasmodium species (notably *P. vivax* and *P. ovale*) that persist in hepatocytes and cause relapsing malaria. Primaquine and tafenoquine are currently the only drugs clinically active against this stage and are essential for "radical cure," though their use is limited by safety concerns. Gametocytes are the sexual forms of Plasmodium species in the blood, responsible for human-to-mosquito transmission and are also susceptible to primaquine. Both stages represent cellular forms of the parasite rather than single molecular targets, making them challenging for drug discovery and structured target annotation. The distinction between hypnozoite and gametocyte stages is critical for accurate research and pharmacological classification.
Primaquine metabolites generate reactive oxygen species and disrupt parasite mitochondria; their efficacy depends on host metabolism (CYP2D6). Tafenoquine has a related mechanism, acting on dormant liver forms.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium species hypnozoite and gametocyte.